https://www.selleckchem.com/pr....oducts/GSK690693.htm
y in the FENIX group. Further research is needed to clarify the treatment pathways for sacral nerve stimulation and to determine its true clinical and cost-effectiveness. Current Controlled Trials ISRCTN16077538. This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in ; Vol. 25, No. 18. See the NIHR Journals Library website for further project information. This project was funded by the National Institute for Health Research (NIHR) Health Tech
Like
Comment
Share
